N/A N=40 Randomized Treatment

Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery

Contraception

Bottom Line

View on ClinicalTrials.gov: NCT03135431 ↗

Enrolled (actual)

Serious AEs

7.9%

Results posted

Jul 2019

Primary outcome: Primary: Mean Difference Between Pre and Postoperative Hemoglobin (g/dl) — 1.4; 1.8 g/dL — p=0.08

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Bilateral Salpingectomy (Procedure); Bilateral Tubal Ligation (Procedure)
Age: Adult, Older Adult · 21+ yrs
Sex: Female
Sponsor: Mayo Clinic
Primary completion: May 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Mean Difference Between Pre and Postoperative Hemoglobin (g/dl)	1.4; 1.8	0.08
SECONDARY Operative Time	16.3; 5.1	—
SECONDARY Estimated Blood Loss	842; 833	0.77

Summary

The purpose of this study is to compare the safety of performing a bilateral tubal ligation vs. bilateral salpingectomy, two procedures performed for permanent sterilization, at the time of cesarean delivery. The investigators want to determine if performing bilateral salpingectomy at the time of cesarean delivery poses any greater risk for blood loss, as compared to a bilateral tubal ligation.

Eligibility Criteria

Inclusion Criteria

Pregnant women
21 years of age or older
Desire permanent sterilization
Scheduled for a Cesarean delivery

Exclusion Criteria

Body Mass Index > 50
Emergent, 'alpha' Cesarean delivery
Single ovary/fallopian tube complex

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03135431). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.